Skip to main content

Cleveland Clinic Comprehensive and Immersive Soft Tissue Pathology

Cleveland Clinic Comprehensive and Immersive Soft Tissue Pathology

Soft tissue pathology training with expert cases and practical diagnostics.
See Reviews Media Formats

Anticipated Release Date: July 31, 2025

Starting at $895.00

Quick Facts



Overview

CME Focused on Soft Tissue Diagnostics

This online CME course offers an in-depth, case-based exploration of soft tissue pathology—from benign lesions and reactive mimics to high-grade sarcomas. Renowned faculty preview a wide range of real-world cases and provide practical strategies for navigating common diagnostic challenges.

 

Through the Cleveland Clinic Comprehensive and Immersive Soft Tissue Pathology continuing medical education course, you’ll develop skills and tools to triage and work up mesenchymal lesions while strengthening your use of immunohistochemistry, molecular tools, and radiologic studies in soft tissue tumor diagnosis. You'll be better equipped to:

  • Identify common and rare soft tissue tumors
  • Recognize diagnostic pitfalls
  • Develop a systematic diagnostic approach
  • Integrate ancillary testing in clinical workflows

Topics / Speakers

The Utility of MDM2 FISH in the Work-Up of Lipomatous Lesions - Karen Fritchie, MD

Lipomatous Tumors - John Goldblum, MD

Spindle Cell Sarcomas with Herringbone – Fascicular Morphology - Brian Rubin, MD, PhD

Pseudosarcomas - Scott Kilpatrick, MD

Acral Soft Tissue Tumors – The Answer is at Your Fingertip - Karen Fritchie, MD

Common Core Biopsy Scenarios in Soft Tissue Pathology - Karen Fritchie, MD

Pediatric Soft Tissue Pathology - Scott Kilpatrick, MD

Periprosthetic Joint Infection - John Reith, MD

Myxoid Soft Tissue Tumors - Steven Billings, MD

S100-Positive Mesenchymal Neoplasms - Karen Fritchie, MD

What’s New in Soft Tissue Pathology? - Karen Fritchie, MD and Josephine Dermawan, MD, PhD

Everyday Cutaneous Soft Tissue Tumors - Steven Billings, MD

The Importance of Molecular Correlation in Mesenchymal Neoplasia - Josephine Dermawan, MD, PhD

Mesenchymal Tumors of the Thorax and Lung - Susan Armstrong, MD

Myoepithelioma…or Not? - Karen Fritchie, MD

Faculty

Course Director

Karen Fritchie, MD

Director, Soft Tissue Pathology

Cleveland Clinic Faculty

Susan Armstrong, MD

Staff Pathologist

Pulmonary Pathology

Steven Billings, MD

Staff Pathologist

Dermatopathology

Soft Tissue Pathology

Josephine Dermawan, MD, PhD

Director, AP Molecular Pathology

Staff Pathologist

Soft Tissue Pathology and Orthopaedic Pathology

John Goldblum, MD

Chair, Division of Pathology

Scott Kilpatrick, MD

Director, Orthopaedic Pathology

Medical Director

Cleveland Clinic Laboratories

John Reith, MD

Staff Pathologist

Orthopaedic Pathology

Brian Rubin, MD, PhD

Chief, Diagnostics Institute

Chair, Department of Pathology and Laboratory Medicine

Accreditation

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

 

American Board of Pathology MOC (ABPath)
Successful completion of this CME activity, which includes participation in the evaluation component, earns 14.75 credits toward the Lifelong Learning requirements for the American Board of Pathology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABPath credit.

 

Credit will be reported within 30 days of claiming credit.

 

Other Health Care Professionals

A certificate of attendance will be provided to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

 

Date of Original Release: July 31, 2025
Date Credits Expire: July 30, 2027

Learning Objectives

At the conclusion of this activity, the participant will be able to:

  • Comprehend the utility of immunohistochemical, molecular techniques and radiology studies in the work-up of soft tissue tumors
  • Develop a work-up strategy for the diagnosis of mesenchymal neoplasms
  • Identify common and uncommon soft tissue tumors
  • Recognize pitfalls commonly encountered in soft tissue pathology

Intended Audience

This activity is designed for pathologists, pathology residents and fellows.

Faculty Affiliations Disclosure

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias. All relevant financial relationships have been mitigated.

 

Disclosure information for all individuals in control of the content of the activity is located on the Faculty Disclosure page in the PDF and print syllabus.

Quick Facts

a CMEinfo video production

Provided by: Cleveland Clinic

Course Director:

Karen Fritchie, MD
Director, Soft Tissue Pathology
Cleveland Clinic

Credits: Earn a maximum of 14.75 AMA PRA Category 1 Credits™

Overview

Specialties

Topics / Speakers

Faculty

Accreditation

Further Information

Further Information

Further Information

Reviews

SKU: PAV587E0